Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010–2017

Published:2019-04-04 Issue:7 Volume:21 Page:1576-1584
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Dennis John M.¹^ORCID,Henley William E.¹,McGovern Andrew P.²,Farmer Andrew J.³,Sattar Naveed⁴,Holman Rury R.⁵^ORCID,Pearson Ewan R.⁶,Hattersley Andrew T.²,Shields Beverley M.²,Jones Angus G.²^ORCID,

Affiliation:

1. Health Statistics GroupInstitute of Health Research, University of Exeter Medical School Exeter UK

2. Institute of Biomedical and Clinical ScienceRoyal Devon and Exeter Hospital Exeter UK

3. Nuffield Department of Primary Care Health SciencesUniversity of Oxford Oxford UK

4. Institute of Cardiovascular and Medical SciencesUniversity of Glasgow Glasgow UK

5. Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and MetabolismUniversity of Oxford Oxford UK

6. Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical SchoolUniversity of Dundee Dundee UK

Funder

Medical Research Council Canada

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13687

Reference39 articles.

1. National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. NICE guideline (NG28).https://www.nice.org.uk/guidance/NG28. Published2015. Accessed May 15 2018.

2. 8. Pharmacologic Approaches to Glycemic Treatment

3. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians

4. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

5. Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glyburide use is associated with a greater likelihood of mortality or rehospitalization after acute coronary syndrome compared to gliclazide use in adults with type 2 diabetes: A cohort study;Diabetes, Obesity and Metabolism;2024-09-09

2. Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes;Diabetologia;2024-08-13

3. Treatment modification patterns of glucose-lowering agents in Saudi Arabia: A retrospective real-world data analysis;Diabetes Research and Clinical Practice;2024-08

4. Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add‐on therapy in drug‐naïve patients with type 2 diabetes (TRIPLE‐AXEL study): A multicentre, randomized, 104‐week, open‐label, active‐controlled trial;Diabetes, Obesity and Metabolism;2024-06-10

5. Patterns of initial and first‐intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010–2020: A retrospective population‐based cohort study;Diabetes, Obesity and Metabolism;2024-04